Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622761 | 12562276 | 1 | I | 20160517 | 20160701 | 20160715 | 20160715 | EXP | GB-MHRA-EYC 00141691 | GB-SA-2016SA122885 | AVENTIS | 60.00 | YR | A | F | Y | 59.41000 | KG | 20160715 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622761 | 12562276 | 1 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | Y | U | UNKNOWN | 18538 | 2.5 | MG | ||||||
| 125622761 | 12562276 | 2 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125622761 | 12562276 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125622761 | 12562276 | DS |
| 125622761 | 12562276 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125622761 | 12562276 | Vision blurred | |
| 125622761 | 12562276 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125622761 | 12562276 | 1 | 20160514 | 20160603 | 0 |